Literature DB >> 33130941

Pre-treatment with Bifidobacterium infantis and its specific antibodies enhance targeted radiosensitization in a murine model for lung cancer.

Juan Yang1,2, ZhouXue Wu1, Yao Chen1,2, ChuanFei Hu1, Dong Li1, Yue Chen2, Saber Imani1, QingLian Wen1, ShaoZhi Fu3,4, JingBo Wu5,6.   

Abstract

PURPOSE: The hypoxic microenvironments of solid tumours are complex and reduce the susceptibility of cancer cells to chemo- and radiotherapy. Conventional radiosensitisers have poor specificity, unsatisfactory therapeutic effects, and significant side effects. Anaerobic bacteria colonise and destroy hypoxic areas of the tumour and consequently enhance the effects of radiation.
METHODS: In this study, we treated a Lewis lung carcinoma transplant mouse model with Bifidobacterium infantis (Bi) combined with its specific monoclonal antibody (mAb) and radiotherapy (RT) to investigate its ability to radiosensitise the tumour. The tumour metabolism and hypoxia in the tumour tissue were monitored by micro-18F-FDG and 18F-FMISO PET/CT imaging. Immunohistochemistry was used to detect phosphorylated histone (γ-H2AX), proliferation (Ki-67), platelet endothelial cell adhesion molecules (CD31), tumour necrosis factor-α (TNF-α), hypoxia-inducible factor-1α (HIF-1α), and glucose transporter 1 (Glut-1) levels.
RESULTS: Tumour growth was slowed and survival time was markedly prolonged in mice subjected to the combination of B. infantis, specific antibody, and radiotherapy. Levels of HIF-1α, Glut-1, Ki-67, and CD31 expression, as well as uptake of FDG and FMISO, were the lowest in the combination-treated mice. In contrast, γ-H2AX and TNF-α expression levels were elevated and hypoxia in tumour tissue was reduced compared with controls.
CONCLUSION: In conclusion, our data indicated that the curative effect of radiotherapy for lung cancer was enhanced by pre-treating mice with a combination of B. infantis and its specific monoclonal antibody.

Entities:  

Keywords:  Bifidobacterium infantis; Lung cancer; Monoclonal antibody; Radio-sensitization; Radiotherapy

Year:  2020        PMID: 33130941     DOI: 10.1007/s00432-020-03434-0

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  33 in total

Review 1.  Exploiting tumour hypoxia in cancer treatment.

Authors:  J Martin Brown; William R Wilson
Journal:  Nat Rev Cancer       Date:  2004-06       Impact factor: 60.716

Review 2.  Modern management of locally advanced cervical carcinoma.

Authors:  Alfonso Dueñas-Gonzalez; Lucely Cetina; Ignacio Mariscal; Jaime de la Garza
Journal:  Cancer Treat Rev       Date:  2003-10       Impact factor: 12.111

3.  Interstitial pH and pO2 gradients in solid tumors in vivo: high-resolution measurements reveal a lack of correlation.

Authors:  G Helmlinger; F Yuan; M Dellian; R K Jain
Journal:  Nat Med       Date:  1997-02       Impact factor: 53.440

4.  Combination bacteriolytic therapy for the treatment of experimental tumors.

Authors:  L H Dang; C Bettegowda; D L Huso; K W Kinzler; B Vogelstein
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-27       Impact factor: 11.205

Review 5.  Angiogenesis in cancer and other diseases.

Authors:  P Carmeliet; R K Jain
Journal:  Nature       Date:  2000-09-14       Impact factor: 49.962

6.  Overcoming the hypoxic barrier to radiation therapy with anaerobic bacteria.

Authors:  Chetan Bettegowda; Long H Dang; Ross Abrams; David L Huso; Larry Dillehay; Ian Cheong; Nishant Agrawal; Scott Borzillary; J Michael McCaffery; E Latice Watson; Kuo-Shyan Lin; Fred Bunz; Kwamena Baidoo; Martin G Pomper; Kenneth W Kinzler; Bert Vogelstein; Shibin Zhou
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-01       Impact factor: 11.205

7.  SATB1 Level Correlates with Ki-67 Expression and Is a Positive Prognostic Factor in Non-small Cell Lung Carcinoma.

Authors:  Natalia Glatzel-Plucinska; Aleksandra Piotrowska; Jedrzej Grzegrzolka; Mateusz Olbromski; Adam Rzechonek; Piotr Dziegiel; Marzenna Podhorska-Okolow
Journal:  Anticancer Res       Date:  2018-02       Impact factor: 2.480

Review 8.  Hypoxia and metabolism. Hypoxia, DNA repair and genetic instability.

Authors:  Robert G Bristow; Richard P Hill
Journal:  Nat Rev Cancer       Date:  2008-03       Impact factor: 60.716

9.  Tumor response to radiotherapy regulated by endothelial cell apoptosis.

Authors:  Monica Garcia-Barros; Francois Paris; Carlos Cordon-Cardo; David Lyden; Shahin Rafii; Adriana Haimovitz-Friedman; Zvi Fuks; Richard Kolesnick
Journal:  Science       Date:  2003-05-16       Impact factor: 47.728

10.  The antitumor function of tumor necrosis factor (TNF), I. Therapeutic action of TNF against an established murine sarcoma is indirect, immunologically dependent, and limited by severe toxicity.

Authors:  E A Havell; W Fiers; R J North
Journal:  J Exp Med       Date:  1988-03-01       Impact factor: 14.307

View more
  3 in total

1.  Radiosensitizing Effect of Bromelain Using Tumor Mice Model via Ki-67 and PARP-1 Inhibition.

Authors:  Mai H Mekkawy; Hanan A Fahmy; Ahmed S Nada; Ola S Ali
Journal:  Integr Cancer Ther       Date:  2021 Jan-Dec       Impact factor: 3.279

2.  Bacteria-driven hypoxia targeting delivery of chemotherapeutic drug proving outcome of breast cancer.

Authors:  Susu Xiao; Huan Shi; Yan Zhang; Yu Fan; Li Wang; Li Xiang; Yanlin Liu; Ling Zhao; Shaozhi Fu
Journal:  J Nanobiotechnology       Date:  2022-04-02       Impact factor: 10.435

Review 3.  Bacteria-Based Synergistic Therapy in the Backdrop of Synthetic Biology.

Authors:  Yawei Bao; Yong Cheng; Wei Liu; Wenguang Luo; Peijie Zhou; Dong Qian
Journal:  Front Oncol       Date:  2022-04-04       Impact factor: 5.738

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.